Pharmaceutical companies are into the business of discovering, manufacturing and sales of drugs. These drugs have to be named, for them to identify the product to its particular pharmaceutical company. Companies decide names for drugs on various factors such as functional or experiential clusters. The names are selected so as to attract attention and score over other competitors. Some names top the charts due to their uniqueness and the fact that they mean nothing yet captivates public attention.

The pharmaceutical companies try and prove mass acceptance by giving names to drugs, which relate to the general people in some way or the other. For example, names ending with the letters "gen" show that they are caring towards the public and these drugs are obtained by working with nature and not against it. Functional names are given to drugs according to the description of what the drug does. Invented names are those that are invented or derived from some other languages. Experiential names highlight the probable experience of the user after the usage of drug.

The company is required to submit an option of at least three names, which are put upon a taxonomy chart before confirmation. This is done after analyzing competition in pharmaceutical business sector. It is also checked that these names are not being repeated for two different drugs. Taxonomy charts help companies to differentiate from the commonly used names from the separate ones in drug market. These names are also regulated by FDA standards. Brand names that catch public eye are very high in value when on sale. Chemical names of drugs also can be registered as brand names. During the clinical testing of the drug the company simultaneously works at developing brand names according to the specified guidelines.

After deciding upon the name the same has to be submitted to the Food and Drug administration office. Therein the FDA authorities strike out the prohibited prefix and stems included in the name.